Maravai LifeSciences
MRVI
NASDAQ
IPO2020
about MRVI
Maravai LifeSciences is a biotechnology company focused on developing innovative solutions for oncology and inflammation, including its lead product, a companion diagnostic that identifies patients who may benefit from checkpoint inhibitor therapies.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $3.15 | $3.26 | $3.12 | $452.47M | 702.02K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.18 | n/a | 12.58 | -98.56% | -108.23% | 0% |